Condition
Malignant Mesothelioma
Estimated Enrollment: 61
Age Group: 18 Years to 120 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CDR0000616162|S0722|U10CA032102
Study First Received: October 8, 2008
Last Updated: January 10, 2017
Estimated Primary Completion Date: April 2014
Primary Outcome Measures:
Progression-Free Survival|Response|Overall Survival|Frequency and Severity of Toxicities
Sponsors and Collaborators:
Southwest Oncology Group|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00770120
